Estimates

Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-08-01.

eToro's consensus tape is in a margin-led upgrade cycle: FY2027 normalized EPS estimates have climbed roughly 16% over the past six months against about 3% for revenue, and the same divergence repeats in FY2028. Recent prints reinforce it - revenue has topped consensus five quarters running - though normalized EPS surprises remain volatile. The street is constructive (10 of 15 ratings positive, none negative), but coverage thins sharply beyond FY2027.

FY2027 normalized EPS up ~16% over six months while revenue estimates rose only ~3%

The same divergence holds in FY2028 - normalized EPS up ~17% over 180 days versus ~7% on revenue - consistent with rising expected margins rather than faster top-line growth.

Currency: USD · Scale: money in millions, absolute · Point-in-time consensus; Δ90d is Now versus 90d.

Metric FY 180d 90d 30d Now Δ90d
EPS (normalized) FY2027 $2.90 $3.06 $3.24 $3.35 +9.5%
EPS (normalized) FY2028 $3.31 $3.49 $3.76 $3.88 +11.3%
Revenue FY2027 $1.04bn $1.05bn $1.06bn $1.07bn +1.9%
Revenue FY2028 $1.06bn $1.09bn $1.11bn $1.13bn +3.5%

Revenue has beaten consensus five quarters straight; normalized EPS swings from -39% to +23%

Current sequences by metric: Revenue: 5 consecutive beats; EPS (normalized): 2 consecutive beats.

Currency: USD · Scale: money in millions, absolute · Consensus is captured before each actual first became effective.

Quarter Metric Consensus Actual Surprise Outcome
Q1 FY2026 Revenue $233.40m $258.15m +10.6% Beat
Q1 FY2026 EPS (normalized) $0.70 $0.86 +22.7% Beat
Q4 FY2025 Revenue $217.96m $226.78m +4.0% Beat
Q4 FY2025 EPS (normalized) $0.60 $0.69 +15.4% Beat
Q3 FY2025 Revenue $208.35m $214.60m +3.0% Beat
Q3 FY2025 EPS (normalized) $0.55 $0.53 -3.8% Miss
Q2 FY2025 Revenue $194.70m $209.63m +7.7% Beat
Q2 FY2025 EPS (normalized) $0.51 $0.31 -39.2% Miss
Q1 FY2025 Revenue $213.42m $217.37m +1.8% Beat
Q1 FY2025 EPS (normalized) $0.63 $0.69 +9.1% Beat

Revenue growth decelerates toward mid-single digits as EBITDA and EPS compound faster

On consensus means, revenue growth eases from ~12% (FY2026) to ~5% (FY2028) while EBITDA rises from ~$359M to ~$481M; note FY2028 rests on far fewer analysts.

Currency: USD · Scale: money in millions, absolute · YoY uses the prior fiscal year from the feed; analyst count and range use the first displayed period.

Metric FY2026E FY2027E FY2028E YoY Analysts Low / high
Revenue $968.17m $1.07bn $1.13bn +11.5% 11 $908.66m / $1.02bn
EBITDA $359.25m $425.96m $480.51m +13.3% 10 $348.00m / $378.37m
EPS (normalized) $2.84 $3.35 $3.88 +25.3% 12 $2.58 / $3.22

Where the street disagrees

Currency: USD · Scale: money in millions, absolute · Spread/mean is absolute high-low divided by absolute mean.

Metric Period Mean Low–high Spread/mean Analysts
Revenue FY2027E $1.07bn $943.98m–$1.19bn 22.9% 12
EBITDA FY2027E $425.96m $384.30m–$491.20m 25.1% 10
Net income (GAAP) FY2027E $305.30m $243.63m–$349.60m 34.7% 12

Street snapshot

Consensus recommendation score is 1.8 (toward buy); the target mean is $56.93 and median $57.

Currency: USD · Scale: money in millions, absolute · Analyst counts shown explicitly.

Street view Reading Analysts
Recommendation mix Buy 8, Outperform 2, Hold 5, Underperform 0, Sell 0 15
Consensus score 1.80 15
Target price mean $56.93; median $57.00; high $90.00; low $42.00 15

Coverage thins sharply beyond FY2027

FY2028 revenue carries just 5 estimates and EBITDA only 3; FY2029 has a single normalized-EPS estimate and little else. Treat outer-year figures as indicative.